Assembly Biosciences ASMB Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $71.1M-1.7% | $72.3M+94.4% | $37.19M+11.9% | $33.25M+3.4% | $32.15M+12.7% | ||
| $64.86M+0.1% | $64.81M+4.8% | $61.84M+5.2% | $58.77M-0.2% | $58.91M+5.3% | ||
| $19.78M+0.9% | $19.61M+4.3% | $18.8M+4.4% | $18M+0.7% | $17.88M-0.7% | ||
| $84.64M+0.3% | $84.42M+4.7% | $80.64M+5.0% | $76.77M0.0% | $76.79M+3.8% | ||
| —— | —— | -$43.45M+0.2% | -$43.52M+2.5% | -$44.63M+1.7% | ||
| $7.16M+19.5% | $6M+24.2% | $4.83M+7.7% | $4.48M-11.1% | $5.04M-9.5% | ||
| —— | —— | -$38.55M+1.1% | -$38.96M+2.4% | -$39.92M+0.6% | ||
| —— | —— | -$4.79+14.2% | -$5.58+10.4% | -$6.23+7.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Assembly Biosciences's revenue?
- Assembly Biosciences (ASMB) generated $71.1M in revenue over the trailing twelve months, up 121.1% year over year.
- Is Assembly Biosciences profitable?
- Assembly Biosciences is not currently profitable: it reported a net loss of $37.3M over the trailing twelve months, a -103.6% net margin.
- What is Assembly Biosciences's earnings per share?
- Assembly Biosciences's diluted EPS over the trailing twelve months is $-3.76.
- Where does Assembly Biosciences's income statement data come from?
- Every line is extracted from Assembly Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
